measuregroup/AID150821

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103377008_AID150821_PMID14643346_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103377492_AID150821_PMID14643346_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103377035_AID150821_PMID14643346_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103170037_AID150821_PMID14643346_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103310529_AID150821_PMID14643346_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103377593_AID150821_PMID14643346_VALUE6
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35372
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Concentration required to inhibit agonist (loperamide) stimulated [35S]GTP-gamma-S, binding to membranes containing the cloned human mu opioid receptor
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103377035 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103377008 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103310529 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103377593 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103170037 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103377492
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID150821

Total number of triples: 17.